Amber Therapeutics Funding: $100M Raised, Series A (2024)

Amber Therapeutics funding overview

Amber Therapeutics is a Biotech company based in London, United Kingdom. Amber Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Amber Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include New Enterprise Associates (NEA), Oxford Science Enterprises, 8VC, F-Prime Capital, Lightstone Ventures, Intuitive Ventures. 6 distinct backers are named across the disclosed rounds.

Amber Therapeutics at a glance

Total raised: $100M
Latest round: Series A
Latest round date: January 2024
Industry: Biotech
Headquarters: London, United Kingdom
Notable investors: New Enterprise Associates (NEA), Oxford Science Enterprises, 8VC, F-Prime Capital, Lightstone Ventures, Intuitive Ventures

Frequently asked about Amber Therapeutics funding

How much has Amber Therapeutics raised?: Amber Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Amber Therapeutics?: New Enterprise Associates (NEA), Oxford Science Enterprises, 8VC, F-Prime Capital, Lightstone Ventures, Intuitive Ventures are named among the investors backing Amber Therapeutics.
What was the latest Amber Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2024.
Where is Amber Therapeutics based?: Amber Therapeutics is based in London, United Kingdom.
What sector does Amber Therapeutics operate in?: Amber Therapeutics is tracked under Biotech from London, United Kingdom, with $100M in disclosed funding.
When did Amber Therapeutics last raise?: The last disclosed Amber Therapeutics round closed in January 2024 at Series A.

Amber Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in London below to benchmark round size and investor mix.

Amber Therapeutics Funding: $100M Raised, Series A (2024)

Amber Therapeutics funding overview

Amber Therapeutics at a glance

Frequently asked about Amber Therapeutics funding

Companies related to Amber Therapeutics (40)

Browse related funding lists (9)